GA
APDNW

Geneva Advisors’s Applied DNA Sciences Inc Warrant APDNW Stock Holding History

Geneva Advisors’s Portfolio APDNW Stock Details APDNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$8K Hold
19,205
– – ﹤0.01% 730
2017
Q1 		$8K Hold
19,205
– – ﹤0.01% 757
2016
Q4 		$10K Buy
+19,205
New +$15.3K ﹤0.01% 752

Other funds holding APDNW

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geneva Advisors's APDNW Position: Q2 2017 in Review

Geneva Advisors held its Applied DNA Sciences Inc Warrant (APDNW) position steady in Q2 2017 at 19,205 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #730.

Geneva Advisors first reported a position in APDNW in Q4 2016 and has held it in 3 quarters since. The position peaked at $10K in Q4 2016. 6 funds tracked by Wall St. Rank hold APDNW as of Q2 2017.

  • Geneva Advisors held 19,205 shares of Applied DNA Sciences Inc Warrant worth $8K as of Q2 2017.
  • Geneva Advisors left its Applied DNA Sciences Inc Warrant share count unchanged in Q2 2017.
  • Applied DNA Sciences Inc Warrant made up ﹤0.01% of Geneva Advisors's portfolio in Q2 2017, its #730 holding.
  • Geneva Advisors first reported a position in Applied DNA Sciences Inc Warrant in Q4 2016 and has held it in 3 quarters since.
  • Geneva Advisors's Applied DNA Sciences Inc Warrant position peaked at $10K in Q4 2016.
  • 6 funds tracked by Wall St. Rank held Applied DNA Sciences Inc Warrant as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.